{
  "schema_version": "0.1.0",
  "id": "fda-drug-shortage:ketorolac-tromethamine-injection",
  "slug": "ketorolac-tromethamine-injection",
  "title": "FDA shortage status: Ketorolac Tromethamine Injection",
  "ingredient": "Ketorolac Tromethamine Injection",
  "status": "current",
  "source_statuses": [
    "Current"
  ],
  "brand_names": [
    "KETOROLAC TROMETHAMINE"
  ],
  "therapeutic_categories": [
    "Analgesia/Addiction"
  ],
  "dosage_forms": [
    "Injection"
  ],
  "routes": [
    "INTRAMUSCULAR",
    "INTRAVENOUS"
  ],
  "package_count": 25,
  "packages": [
    {
      "package_ndc": "62332-599-25",
      "product_ndc": "62332-599",
      "company_name": "Alembic Pharmaceuticals",
      "manufacturer_name": "Alembic Pharmaceuticals Inc.",
      "presentation": "Ketorolac Tromethamine, Injection, 15 mg/1 mL (NDC 62332-599-25)",
      "availability": "Available",
      "dosage_form": "Injection",
      "routes": [
        "INTRAMUSCULAR",
        "INTRAVENOUS"
      ],
      "update_date": "05/15/2026",
      "initial_posting_date": "03/23/2018",
      "source_url": "https://api.fda.gov/drug/shortages.json"
    },
    {
      "package_ndc": "62332-600-25",
      "product_ndc": "62332-599",
      "company_name": "Alembic Pharmaceuticals",
      "manufacturer_name": "Alembic Pharmaceuticals Inc.",
      "presentation": "Ketorolac Tromethamine, Injection, 30 mg/1 mL (NDC 62332-600-25)",
      "availability": "Available",
      "dosage_form": "Injection",
      "routes": [
        "INTRAMUSCULAR",
        "INTRAVENOUS"
      ],
      "update_date": "05/15/2026",
      "initial_posting_date": "03/23/2018",
      "source_url": "https://api.fda.gov/drug/shortages.json"
    },
    {
      "package_ndc": "62332-601-25",
      "product_ndc": "62332-599",
      "company_name": "Alembic Pharmaceuticals",
      "manufacturer_name": "Alembic Pharmaceuticals Inc.",
      "presentation": "Ketorolac Tromethamine, Injection, 60 mg/2 mL (NDC 62332-601-25)",
      "availability": "Available",
      "dosage_form": "Injection",
      "routes": [
        "INTRAMUSCULAR",
        "INTRAVENOUS"
      ],
      "update_date": "05/15/2026",
      "initial_posting_date": "03/23/2018",
      "source_url": "https://api.fda.gov/drug/shortages.json"
    },
    {
      "package_ndc": "0338-0069-10",
      "product_ndc": "0338-0069",
      "company_name": "Baxter Healthcare",
      "manufacturer_name": "Baxter Healthcare Corporation",
      "presentation": "Ketorolac Tromethamine, Injection, 15 mg/1 mL (NDC 0338-0069-10)",
      "availability": "Unavailable",
      "dosage_form": "Injection",
      "routes": [
        "INTRAMUSCULAR",
        "INTRAVENOUS"
      ],
      "update_date": "08/17/2026",
      "initial_posting_date": "06/06/2018",
      "source_url": "https://api.fda.gov/drug/shortages.json"
    },
    {
      "package_ndc": "0338-0072-25",
      "product_ndc": "0338-0069",
      "company_name": "Baxter Healthcare",
      "manufacturer_name": "Baxter Healthcare Corporation",
      "presentation": "Ketorolac Tromethamine, Injection, 30 mg/1 mL (NDC 0338-0072-25)",
      "availability": "Unavailable",
      "dosage_form": "Injection",
      "routes": [
        "INTRAMUSCULAR",
        "INTRAVENOUS"
      ],
      "update_date": "08/17/2026",
      "initial_posting_date": "06/06/2018",
      "source_url": "https://api.fda.gov/drug/shortages.json"
    },
    {
      "package_ndc": "63323-161-01",
      "product_ndc": "63323-161",
      "company_name": "Fresenius Kabi USA, LLC",
      "manufacturer_name": "Fresenius Kabi USA, LLC",
      "presentation": "Ketorolac Tromethamine, Injection, 15 mg/1 mL (NDC 63323-161-01)",
      "availability": "Available",
      "dosage_form": "Injection",
      "routes": [
        "INTRAMUSCULAR",
        "INTRAVENOUS"
      ],
      "update_date": "08/04/2026",
      "initial_posting_date": "03/23/2018",
      "source_url": "https://api.fda.gov/drug/shortages.json"
    },
    {
      "package_ndc": "76045-107-10",
      "product_ndc": "76045-104",
      "company_name": "Fresenius Kabi USA, LLC",
      "manufacturer_name": "Fresenius Kabi USA, LLC",
      "presentation": "Ketorolac Tromethamine, Injection, 15 mg/1 mL (NDC 76045-107-10)",
      "availability": "Unavailable",
      "dosage_form": "Injection",
      "routes": [
        "INTRAMUSCULAR",
        "INTRAVENOUS"
      ],
      "update_date": "08/04/2026",
      "initial_posting_date": "03/23/2018",
      "source_url": "https://api.fda.gov/drug/shortages.json"
    },
    {
      "package_ndc": "63323-162-01",
      "product_ndc": "63323-161",
      "company_name": "Fresenius Kabi USA, LLC",
      "manufacturer_name": "Fresenius Kabi USA, LLC",
      "presentation": "Ketorolac Tromethamine, Injection, 30 mg/1 mL (NDC 63323-162-01)",
      "availability": "Unavailable",
      "dosage_form": "Injection",
      "routes": [
        "INTRAMUSCULAR"
      ],
      "update_date": "08/04/2026",
      "initial_posting_date": "03/23/2018",
      "source_url": "https://api.fda.gov/drug/shortages.json"
    },
    {
      "package_ndc": "63323-162-02",
      "product_ndc": "63323-161",
      "company_name": "Fresenius Kabi USA, LLC",
      "manufacturer_name": "Fresenius Kabi USA, LLC",
      "presentation": "Ketorolac Tromethamine, Injection, 30 mg/1 mL (NDC 63323-162-02)",
      "availability": "Unavailable",
      "dosage_form": "Injection",
      "routes": [
        "INTRAMUSCULAR"
      ],
      "update_date": "08/04/2026",
      "initial_posting_date": "03/23/2018",
      "source_url": "https://api.fda.gov/drug/shortages.json"
    },
    {
      "package_ndc": "76045-104-10",
      "product_ndc": "76045-104",
      "company_name": "Fresenius Kabi USA, LLC",
      "manufacturer_name": "Fresenius Kabi USA, LLC",
      "presentation": "Ketorolac Tromethamine, Injection, 30 mg/1 mL (NDC 76045-104-10)",
      "availability": "Unavailable",
      "dosage_form": "Injection",
      "routes": [
        "INTRAMUSCULAR",
        "INTRAVENOUS"
      ],
      "update_date": "08/04/2026",
      "initial_posting_date": "03/23/2018",
      "source_url": "https://api.fda.gov/drug/shortages.json"
    },
    {
      "package_ndc": "76045-105-20",
      "product_ndc": "76045-104",
      "company_name": "Fresenius Kabi USA, LLC",
      "manufacturer_name": "Fresenius Kabi USA, LLC",
      "presentation": "Ketorolac Tromethamine, Injection, 60 mg/2 mL (NDC 76045-105-20)",
      "availability": "Unavailable",
      "dosage_form": "Injection",
      "routes": [
        "INTRAMUSCULAR"
      ],
      "update_date": "08/04/2026",
      "initial_posting_date": "03/23/2018",
      "source_url": "https://api.fda.gov/drug/shortages.json"
    },
    {
      "package_ndc": "25021-700-01",
      "product_ndc": "25021-700",
      "company_name": "Gland Pharma Limited",
      "manufacturer_name": "Sagent Pharmaceuticals",
      "presentation": "Ketorolac Tromethamine, Injection, 15 mg/1 mL (NDC 25021-700-01)",
      "availability": "Available",
      "dosage_form": "Injection",
      "routes": [
        "INTRAMUSCULAR",
        "INTRAVENOUS"
      ],
      "update_date": "07/22/2026",
      "initial_posting_date": "03/23/2018",
      "source_url": "https://api.fda.gov/drug/shortages.json"
    },
    {
      "package_ndc": "25021-701-01",
      "product_ndc": "25021-700",
      "company_name": "Gland Pharma Limited",
      "manufacturer_name": "Sagent Pharmaceuticals",
      "presentation": "Ketorolac Tromethamine, Injection, 30 mg/1 mL (NDC 25021-701-01)",
      "availability": "Available",
      "dosage_form": "Injection",
      "routes": [
        "INTRAMUSCULAR",
        "INTRAVENOUS"
      ],
      "update_date": "07/22/2026",
      "initial_posting_date": "03/23/2018",
      "source_url": "https://api.fda.gov/drug/shortages.json"
    },
    {
      "package_ndc": "25021-701-02",
      "product_ndc": "25021-700",
      "company_name": "Gland Pharma Limited",
      "manufacturer_name": "Sagent Pharmaceuticals",
      "presentation": "Ketorolac Tromethamine, Injection, 30 mg/1 mL (NDC 25021-701-02)",
      "availability": "Available",
      "dosage_form": "Injection",
      "routes": [
        "INTRAMUSCULAR",
        "INTRAVENOUS"
      ],
      "update_date": "07/22/2026",
      "initial_posting_date": "03/23/2018",
      "source_url": "https://api.fda.gov/drug/shortages.json"
    },
    {
      "package_ndc": "72266-118-25",
      "product_ndc": "72266-118",
      "company_name": "Gland Pharma Limited",
      "manufacturer_name": "FOSUN PHARMA USA INC",
      "presentation": "Ketorolac Tromethamine, Injection, 30 mg/1 mL (NDC 72266-118-25)",
      "availability": "Available",
      "dosage_form": "Injection",
      "routes": [
        "INTRAMUSCULAR",
        "INTRAVENOUS"
      ],
      "update_date": "07/22/2026",
      "initial_posting_date": "06/06/2018",
      "source_url": "https://api.fda.gov/drug/shortages.json"
    },
    {
      "package_ndc": "72266-119-25",
      "product_ndc": "72266-118",
      "company_name": "Gland Pharma Limited",
      "manufacturer_name": "FOSUN PHARMA USA INC",
      "presentation": "Ketorolac Tromethamine, Injection, 30 mg/1 mL (NDC 72266-119-25)",
      "availability": "Available",
      "dosage_form": "Injection",
      "routes": [
        "INTRAMUSCULAR"
      ],
      "update_date": "07/22/2026",
      "initial_posting_date": "06/06/2018",
      "source_url": "https://api.fda.gov/drug/shortages.json"
    },
    {
      "package_ndc": "0641-6041-25",
      "product_ndc": "0641-6041",
      "company_name": "Hikma Pharmaceuticals USA, Inc.",
      "manufacturer_name": "Hikma Pharmaceuticals USA Inc.",
      "presentation": "Ketorolac Tromethamine, Injection, 15 mg/1 mL (NDC 0641-6041-25)",
      "availability": "Unavailable",
      "dosage_form": "Injection",
      "routes": [
        "INTRAMUSCULAR",
        "INTRAVENOUS"
      ],
      "update_date": "08/13/2026",
      "initial_posting_date": "06/06/2018",
      "source_url": "https://api.fda.gov/drug/shortages.json"
    },
    {
      "package_ndc": "0641-6042-25",
      "product_ndc": "0641-6041",
      "company_name": "Hikma Pharmaceuticals USA, Inc.",
      "manufacturer_name": "Hikma Pharmaceuticals USA Inc.",
      "presentation": "Ketorolac Tromethamine, Injection, 30 mg/1 mL (NDC 0641-6042-25)",
      "availability": "Unavailable",
      "dosage_form": "Injection",
      "routes": [
        "INTRAMUSCULAR",
        "INTRAVENOUS"
      ],
      "update_date": "08/13/2026",
      "initial_posting_date": "06/06/2018",
      "source_url": "https://api.fda.gov/drug/shortages.json"
    },
    {
      "package_ndc": "0641-6043-25",
      "product_ndc": "0641-6041",
      "company_name": "Hikma Pharmaceuticals USA, Inc.",
      "manufacturer_name": "Hikma Pharmaceuticals USA Inc.",
      "presentation": "Ketorolac Tromethamine, Injection, 30 mg/1 mL (NDC 0641-6043-25)",
      "availability": "Unavailable",
      "dosage_form": "Injection",
      "routes": [
        "INTRAMUSCULAR"
      ],
      "update_date": "08/13/2026",
      "initial_posting_date": "06/06/2018",
      "source_url": "https://api.fda.gov/drug/shortages.json"
    },
    {
      "package_ndc": "0409-3793-01",
      "product_ndc": "0409-3793",
      "company_name": "Hospira, Inc., a Pfizer Company",
      "manufacturer_name": "Hospira, Inc.",
      "presentation": "Ketorolac Tromethamine, Injection, 15 mg/1 mL (NDC 0409-3793-01)",
      "availability": "Unavailable",
      "dosage_form": "Injection",
      "routes": [
        "INTRAMUSCULAR",
        "INTRAVENOUS"
      ],
      "update_date": "08/07/2026",
      "initial_posting_date": "03/26/2018",
      "source_url": "https://api.fda.gov/drug/shortages.json"
    },
    {
      "package_ndc": "0409-3795-01",
      "product_ndc": "0409-3793",
      "company_name": "Hospira, Inc., a Pfizer Company",
      "manufacturer_name": "Hospira, Inc.",
      "presentation": "Ketorolac Tromethamine, Injection, 30 mg/1 mL (NDC 0409-3795-01)",
      "availability": "Unavailable",
      "dosage_form": "Injection",
      "routes": [
        "INTRAMUSCULAR",
        "INTRAVENOUS"
      ],
      "update_date": "08/07/2026",
      "initial_posting_date": "03/26/2018",
      "source_url": "https://api.fda.gov/drug/shortages.json"
    },
    {
      "package_ndc": "0409-3796-01",
      "product_ndc": "0409-3793",
      "company_name": "Hospira, Inc., a Pfizer Company",
      "manufacturer_name": "Hospira, Inc.",
      "presentation": "Ketorolac Tromethamine, Injection, 60 mg/2 mL (30 mg/mL) (NDC 0409-3796-01)",
      "availability": "Unavailable",
      "dosage_form": "Injection",
      "routes": [
        "INTRAMUSCULAR"
      ],
      "update_date": "08/07/2026",
      "initial_posting_date": "03/26/2018",
      "source_url": "https://api.fda.gov/drug/shortages.json"
    },
    {
      "package_ndc": "25021-700-01",
      "product_ndc": "25021-700",
      "company_name": "Sagent Pharmaceuticals",
      "manufacturer_name": "Sagent Pharmaceuticals",
      "presentation": "Ketorolac Tromethamine, Injection, 15 mg/1 mL (NDC 25021-700-01)",
      "availability": "Limited Availability",
      "dosage_form": "Injection",
      "routes": [
        "INTRAMUSCULAR",
        "INTRAVENOUS"
      ],
      "update_date": "08/18/2026",
      "initial_posting_date": "03/26/2018",
      "source_url": "https://api.fda.gov/drug/shortages.json"
    },
    {
      "package_ndc": "25021-701-01",
      "product_ndc": "25021-700",
      "company_name": "Sagent Pharmaceuticals",
      "manufacturer_name": "Sagent Pharmaceuticals",
      "presentation": "Ketorolac Tromethamine, Injection, 30 mg/1 mL (NDC 25021-701-01)",
      "availability": "Available",
      "dosage_form": "Injection",
      "routes": [
        "INTRAMUSCULAR",
        "INTRAVENOUS"
      ],
      "update_date": "08/18/2026",
      "initial_posting_date": "03/26/2018",
      "source_url": "https://api.fda.gov/drug/shortages.json"
    },
    {
      "package_ndc": "25021-701-02",
      "product_ndc": "25021-700",
      "company_name": "Sagent Pharmaceuticals",
      "manufacturer_name": "Sagent Pharmaceuticals",
      "presentation": "Ketorolac Tromethamine, Injection, 30 mg/1 mL (NDC 25021-701-02)",
      "availability": "Available",
      "dosage_form": "Injection",
      "routes": [
        "INTRAMUSCULAR",
        "INTRAVENOUS"
      ],
      "update_date": "08/18/2026",
      "initial_posting_date": "03/26/2018",
      "source_url": "https://api.fda.gov/drug/shortages.json"
    }
  ],
  "availability_counts": {
    "Available": 11,
    "Limited Availability": 1,
    "Unavailable": 13
  },
  "initial_posting_date": "03/23/2018",
  "latest_source_update": "08/18/2026",
  "source_updated_at": "2026-08-22",
  "official_url": "https://api.fda.gov/drug/shortages.json",
  "source_name": "U.S. Food and Drug Administration openFDA Drug Shortages",
  "source_license_url": "https://open.fda.gov/license/",
  "retrieved_at": "2026-08-22T15:54:11+00:00",
  "unknowns": {
    "local_availability": "Unknown. FDA status is nationwide and is not local inventory.",
    "clinical_alternatives": "Not provided. CiteFacts does not publish treatment or substitution advice.",
    "resolution_date": "Unknown unless an FDA source row provides an update date."
  },
  "derivations": {
    "status": "current when a grouped FDA row has Current; otherwise it preserves the available FDA Resolved, Discontinuation, or not-current state.",
    "ingredient_page": "Grouped by FDA generic_name, falling back to openFDA.generic_name.",
    "availability_counts": "Count of non-empty FDA package availability values; it is not a claim about local supply."
  }
}